HLA-C*06:02-independent, gender-related association of PSORS1C3 and PSORS1C1/CDSN single-nucleotide polymorphisms with risk and severity of psoriasis
Andrzej Wiśniewski(Ludwik Hirszfeld Institute of Immunology and Experimental Therapy), Piotr Kuśnierczyk(Immungenetics (Germany)), Łukasz Matusiak(Wrocław University of Science and Technology), Aneta Szczerkowska‐Dobosz(Gdańsk Medical University), Izabela Nowak(Ludwik Hirszfeld Institute of Immunology and Experimental Therapy)
Cited by 27
Related Papers
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
|Journal of the European Academy of Dermatology and Venereology|2015|1.1k
Hidradenitis suppurativa
|Nature Reviews Disease Primers|2020|567
Development and validation of the International Hidradenitis Suppurativa Severity Score System ( <scp>IHS</scp> 4), a novel dynamic scoring system to assess <scp>HS</scp> severity
|British Journal of Dermatology|2017|467
Diagnostic delay in hidradenitis suppurativa is a global problem
|British Journal of Dermatology|2015|392
Psychophysical Aspects of Hidradenitis Suppurativa
|Acta Dermato Venereologica|2010|302